New collaborative publication with the Deiters lab, generating and testing conditionally activated benzylguanine compounds. These new molecules are key building blocks for our efforts to engineer CAR T cells with greater tumor specificity, gating activity through the unique chemical environment of tumors. Congrats to all co-authors contributing to this work! Link
New manuscript with Deiters lab published in Bioconjugate Chemistry.
Previous
Previous
New review paper on small-molecule control of CAR T cells published in Nat. Rev. Chem.
Next
Next